Newsletter | April 8, 2020

04.08.20 -- A Path To Biotech For Young Women

 
Sponsor

Formulation and tech transfer present perennial challenges for biopharma. That's why they're focal points at Catalent. Learn how we're leveraging state-of-the-art automation technologies to enable high-throughput formulation development and how we are applying innovative approaches to process management to address equipment and materials challenges during tech transfer.

From The Editor
A Path To Biotech For Young Women
 
By Louis Garguilo, Chief Editor, Outsourced Pharma

“I’m one of the original founders at Aristea, a start-up company here in San Diego.” One of the founders? Sara McCutchan takes the conference room by surprise, although by now we should be inured to how thoroughly younger generations are contributing to our biopharma industry.

When Employees Become The Supply Chain: Leadership In A Pandemic
By Louis Garguilo, Chief Editor, Outsourced Pharma

With your newly dispersed workforce, employees have in effect become a part of your external supply chain. How can leaders help them get through this time of uncertainty, and continue to perform at a high level? Here's some advice.

Featured Editorial
Expert Advice For All Facets Of Managing Your External CMC Partners
 

More outsourcing needs to translate to better outsourcing — improved efficiencies, productivity, speed, and CDMO relationships. Easier said than done. But no internal function at a biotech or pharma company can do more toward accomplishing these improvements than the CMC (chemistry, manufacturing, and controls) group.

Industry Insights
Keeping Pace With Increasing Biopharmaceutical Manufacturing Demand
Article | By Michelle Calhoun, AbbVie

Today’s biologics pipeline is healthy, but forecasts indicate growth so robust the industry risks being ill-equipped to meet demand. Will contract manufacturers rise to the demand challenge?

Decision Timeline: Considerations In Selecting An Outsourced Solution
Article | Thermo Fisher Scientific

The traditional business model for in-house pharma manufacturing is nearly a thing of the past. More companies are turning to outsourcing to achieve flexibility and efficiency in a highly competitive market. 

U.S. Clinical Labels 101: Steps To Ensure Accuracy
Article | Ropack Pharma Solutions

Determining a drug candidate’s probability of commercial success is a most significant phase in the drug development process. There is no room for error.

An End-To-End, Semicontinuous Process For mAb Production
Application Note | GE Healthcare Life Sciences

See how the different unit operations in a laboratory-scale monoclonal antibody (mAb) process can be connected and integrated into a semicontinuous process.

Are You Protecting Your Employees During HPAPI Manufacturing?
Q&A | Ajinomoto Bio-Pharma Services

As biomanufacturers venture into the rapidly growing market of HPAPIs it is important to consider whether they have the resources and capabilities to protect their products and their employees.

Sponsor
  Remote Auditing For GMP Compliance During COVID-19: Challenges And Opportunities
 

April 16, 2020 | 1:00 PM EDTM

Ensure your GMP audits and compliance don’t suffer due to COVID-19 restrictions. Register now to learn best practices for remote GMP auditing!

Solutions
Particle Control In Biopharmaceuticals
Lonza Pharma & Biotech
Life Science Leader Magazine
 

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.